Tectonic Therapeutic, Inc.: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 9, 2018 and accepted by EDGAR at Aug 9, 2018, 08:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2018-04-01 to 2018-06-30 | $7.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-01-01 to 2018-06-30 | $13.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | −$9.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | −$17.3m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2018-04-01 to 2018-06-30 | −$10.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | −$18.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | −$2.98 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | −$7.16 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | −$14.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-01-01 to 2018-06-30 | $424.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-06-30 | $155.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $156.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $158.7m | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $9.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $10.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-06-30 | $148.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-18-243527. Last ingested by Listed: Nov 5, 2026, 19:21 ET. Listed shows no prices and gives no investment advice.